Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000339705

Medchemexpress LLC Cabozantinib (Standard) | 849217-68-1 | 99.3% | 25 MG
SDP

Catalog No. 5000339705
Encompass_Preferred

Cabozantinib (Standard) is the analytical standard of Cabozantinib, a potent and orally active inhibitor of VEGFR2 and MET with IC50 values of 0.035 nM and 1.3 nM, respectively. It also significantly inhibits KIT, RET, AXL, TIE2, and FLT3. This product exhibits antiangiogenic activity, disrupting tumor vasculature and promoting apoptosis in tumor and endothelial cells. It is intended for research and analytical applications.

  • It is the analytical standard for Cabozantinib.
  • It serves as a potent and orally active inhibitor of VEGFR2 and MET.
  • It demonstrates strong inhibition of various other kinases including KIT, RET, AXL, TIE2, and FLT3.
  • It possesses antiangiogenic properties.
  • It disrupts tumor vasculature and induces apoptosis in tumor and endothelial cells.
  • It is suitable for research and analytical applications, including qualitative, quantitative, and methodological research experiments in HPLC, GC, and MS.

Catalog No. 50-003-39705 Supplier Medchemexpress LLC Supplier No. 25MGHY13016R
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Cabozantinib (Standard) is the analytical standard of Cabozantinib, a potent and orally active inhibitor of VEGFR2 and MET with IC50 values of 0.035 nM and 1.3 nM, respectively. It also significantly inhibits KIT, RET, AXL, TIE2, and FLT3. This product exhibits antiangiogenic activity, disrupting tumor vasculature and promoting apoptosis in tumor and endothelial cells. It is intended for research and analytical applications.

  • It is the analytical standard for Cabozantinib.
  • It serves as a potent and orally active inhibitor of VEGFR2 and MET.
  • It demonstrates strong inhibition of various other kinases including KIT, RET, AXL, TIE2, and FLT3.
  • It possesses antiangiogenic properties.
  • It disrupts tumor vasculature and induces apoptosis in tumor and endothelial cells.
  • It is suitable for research and analytical applications, including qualitative, quantitative, and methodological research experiments in HPLC, GC, and MS.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.